We sit down with you and build your perfect lead list. Book a call with founders.

BenchSci Analysis: $158M Raised

What is BenchSci?

BenchSci is a leader in AI solutions for preclinical research and development. Their ASCEND platform uniquely integrates a knowledge graph and ontological knowledge base to enhance decision-making in biomedical research. This approach significantly improves experimental productivity and uncovers novel insights into disease biology.

HQ Country
Toronto, Canada
Employees
201-500
Founded
2015
Industry
SaaS, AI/ML, HealthTech

Product Features & Capabilities

  • ASCEND AI platform for disease biology research
  • Proprietary ontology knowledge base for evidence mapping
  • Multi-modal AI for data harmonization
  • Specialized AI assistants for pharma workflows
  • Enterprise integrations for internal data and reporting.

How much BenchSci raised

Series D - $95 million

May 25, 2023
Lead Investor: Generation Investment Management, Inovia Capital, TCV, Golden Ventures, F-Prime Capital

Series C - $63 million

January 24, 2022
Lead Investor: Inovia Capital, TCV

Financial Overview

$158MTotal Raised
Series D$95 million
May 25, 2023
Investors: Generation Investment Management, Inovia Capital, TCV, Golden Ventures, F-Prime Capital
Series C$63 million
January 24, 2022
Investors: Inovia Capital, TCV
Want to research more data points on BenchSci?
Start with Extruct